IS5700A - Aðferð til að koma í veg fyrir krabbamein í blöðruhálskirtli með lyfjagjöf - Google Patents

Aðferð til að koma í veg fyrir krabbamein í blöðruhálskirtli með lyfjagjöf

Info

Publication number
IS5700A
IS5700A IS5700A IS5700A IS5700A IS 5700 A IS5700 A IS 5700A IS 5700 A IS5700 A IS 5700A IS 5700 A IS5700 A IS 5700A IS 5700 A IS5700 A IS 5700A
Authority
IS
Iceland
Prior art keywords
prostate cancer
administration
preventing prostate
intraepithelial neoplasia
preventing
Prior art date
Application number
IS5700A
Other languages
English (en)
Other versions
IS2213B (is
Inventor
S. Steiner Mitchell
Raghow Sharon
Original Assignee
The University Of Tennessee Research Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The University Of Tennessee Research Corporation filed Critical The University Of Tennessee Research Corporation
Publication of IS5700A publication Critical patent/IS5700A/is
Publication of IS2213B publication Critical patent/IS2213B/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IS5700A 1998-05-07 2000-11-01 Lyf til að meðhöndla innanþekjuæxlismyndun í blöðruhálskirtli IS2213B (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8460298P 1998-05-07 1998-05-07
PCT/US1999/010146 WO1999056739A1 (en) 1998-05-07 1999-05-07 A method for chemoprevention of prostate cancer

Publications (2)

Publication Number Publication Date
IS5700A true IS5700A (is) 2000-11-01
IS2213B IS2213B (is) 2007-03-15

Family

ID=22186034

Family Applications (2)

Application Number Title Priority Date Filing Date
IS5700A IS2213B (is) 1998-05-07 2000-11-01 Lyf til að meðhöndla innanþekjuæxlismyndun í blöðruhálskirtli
IS8354A IS8354A (is) 1998-05-07 2006-03-15 Aðferð til að koma í veg fyrir krabbamein í blöðruhálskirtli með lyfjagjöf

Family Applications After (1)

Application Number Title Priority Date Filing Date
IS8354A IS8354A (is) 1998-05-07 2006-03-15 Aðferð til að koma í veg fyrir krabbamein í blöðruhálskirtli með lyfjagjöf

Country Status (26)

Country Link
US (1) US6265448B1 (is)
EP (3) EP2277514A1 (is)
JP (2) JP4482229B2 (is)
AT (1) ATE283043T1 (is)
AU (1) AU761435B2 (is)
BG (1) BG65597B1 (is)
CA (1) CA2323809C (is)
CZ (1) CZ300960B6 (is)
DE (2) DE69922131T2 (is)
DK (1) DK1003496T3 (is)
EA (1) EA003466B1 (is)
ES (1) ES2145730T3 (is)
HR (1) HRP20000729A2 (is)
HU (1) HUP0102068A3 (is)
IL (3) IL138437A0 (is)
IS (2) IS2213B (is)
NO (1) NO20005625L (is)
NZ (1) NZ527522A (is)
PL (1) PL207462B1 (is)
PT (1) PT1003496E (is)
SI (1) SI1003496T1 (is)
SK (1) SK16642000A3 (is)
TR (1) TR200003269T2 (is)
UA (1) UA74532C2 (is)
WO (1) WO1999056739A1 (is)
YU (1) YU68600A (is)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040186185A1 (en) * 1998-05-07 2004-09-23 Steiner Mitchell S. Method for treatment and chemoprevention of prostate cancer
US20040092602A1 (en) * 1998-05-07 2004-05-13 Steiner Mitchell S. Method for treatment and chemoprevention of prostate cancer
PT1003496E (pt) * 1998-05-07 2005-04-29 Univ Tennessee Res Corp Medicamento para tratamento de neoplasia intra-epitelial prostatica
US6413533B1 (en) * 1998-05-07 2002-07-02 The University Of Tennessee Research Corporation Method for chemoprevention of prostate cancer
US6410043B1 (en) * 1998-05-07 2002-06-25 The University Of Tennessee Research Corporation Method for chemoprevention of prostate cancer
US20030130316A1 (en) * 2000-03-20 2003-07-10 Steiner Mitchell S. Method for chemoprevention of prostate cancer
US6642274B1 (en) 1999-09-09 2003-11-04 Gary W. Neal Methods and compositions for preventing and treating prostate disorders
EP1214039A2 (en) * 1999-09-09 2002-06-19 Androsolutions, Inc. Methods and compositions for preventing and treating urinary tract disorders
US20050080143A1 (en) * 2001-11-29 2005-04-14 Steiner Mitchell S. Treatment of androgen-deprivation induced osteoporosis
US20040214898A1 (en) * 2001-11-29 2004-10-28 Steiner Mitchell S. Methods for treating hot flashes
US20080249183A1 (en) * 2001-11-29 2008-10-09 Steiner Mitchell S Treatment of androgen-deprivation induced osteoporosis
US20070197664A1 (en) * 2001-11-29 2007-08-23 Steiner Mitchell S Prevention and treatment of androgen-deprivation induced osteoporosis
US20040213841A1 (en) * 2001-11-29 2004-10-28 Steiner Mitchell S Methods for treating hot flashes and gynecomastia
US20060269611A1 (en) * 2001-11-29 2006-11-30 Steiner Mitchell S Prevention and treatment of androgen-deprivation induced osteoporosis
US7524866B2 (en) * 2001-11-29 2009-04-28 Gtx, Inc. Prevention and treatment of androgen—deprivation induced osteoporosis
IL162144A0 (en) 2001-11-29 2005-11-20 Gtx Inc Prevention and treatment of androgen-deprivation induced osteoporosis
US20040096510A1 (en) * 2001-11-29 2004-05-20 Steiner Mitchell S. Prevention and treatment of androgen-deprivation induced osteoporosis
US7332525B2 (en) * 2003-01-17 2008-02-19 Castle Erik P Method of treatment of prostate cancer and composition for treatment thereof
US7070816B2 (en) * 2003-12-05 2006-07-04 New Chapter, Inc. Methods for treating prostatic intraepithelial neoplasia with herbal compositions
US20050208159A1 (en) * 2004-03-16 2005-09-22 Kang Kyung S Phytoestrogenic composition comprising an extract of chinese licorice root, liquiritin or isoliquiritin
US20060019989A1 (en) * 2004-07-21 2006-01-26 Steiner Mitchell S Compositions comprising 5-alpha reductase inhibitors and SERMs and methods of use thereof
WO2006052922A2 (en) * 2004-11-08 2006-05-18 Eastman Chemical Company Pharmaceutical formulations of cyclodextrins and selective estrogen receptor modulator compounds
US20060105045A1 (en) * 2004-11-08 2006-05-18 Buchanan Charles M Cyclodextrin solubilizers for liquid and semi-solid formulations
US20060270641A1 (en) * 2005-05-31 2006-11-30 Steiner Mitchell S Method for chemoprevention of prostate cancer
USD969722S1 (en) 2021-09-28 2022-11-15 Wagner Delima Stabilizing wedge pad

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4329364A (en) 1974-09-11 1982-05-11 Schering Corporation Antiandrogenic agents and methods for the treatment of androgen dependent disease states
US4474813A (en) 1980-10-24 1984-10-02 Schering Corporation Pharmaceutical preparations comprising flutamide
FI77839C (fi) * 1982-05-27 1989-05-10 Farmos Oy Foerfarande foer framstaellning av nya terapeutiskt effektiva trifenylalkan- och alkenderivat.
GB2126576B (en) * 1982-06-25 1985-06-19 Farmos Group Limited Alkane and alkene derivatives
US5491173A (en) 1982-06-25 1996-02-13 Orion-Yhtyma Oy Tri-phenyl alkene derivatives and their preparation and use
US5595985A (en) 1989-03-10 1997-01-21 Endorecherche Inc. Combination therapy for prophylaxis and/or treatment of benign prostatic hyperplasia
US4990538A (en) 1989-08-23 1991-02-05 Harris Adrian L Use of toremifene and its metabolites for the reversal of multidrug resistance of cancer cells against cytotoxic drugs
GB9126209D0 (en) 1991-12-10 1992-02-12 Orion Yhtymae Oy Drug formulations for parenteral use
GB9207437D0 (en) 1992-04-03 1992-05-20 Orion Yhtymae Oy Topical administration of toremifene and its metabolites
ATE198271T1 (de) * 1992-12-01 2001-01-15 Biotie Therapies Oy Syndecan-stimulierung der zellulären differenzierung
US5595722A (en) 1993-01-28 1997-01-21 Neorx Corporation Method for identifying an agent which increases TGF-beta levels
EP0710116B1 (en) 1993-05-13 2008-09-03 Poniard Pharmaceuticals, Inc. Prevention and treatment of pathologies associated with abnormally proliferative smooth muscle cells
HUT74425A (en) 1993-08-09 1996-12-30 Baral A method for sensitization of cancer for killer cell mediated lysis
US5650425A (en) 1994-04-04 1997-07-22 Pharmos Corporation Permanently ionic derivatives of steroid hormones and their antagonists
US5629007A (en) 1995-03-21 1997-05-13 Eli Lilly And Company Method of preventing prostatic cancer development
US5635197A (en) 1995-03-21 1997-06-03 Eli Lilly And Company Treatment and prevention of prostatic cancer metastasis
ZA984650B (en) * 1997-06-19 1998-12-08 Orion Corp Intratumoral administration of triphenylethylenes for the treatment of cancer
PT1003496E (pt) * 1998-05-07 2005-04-29 Univ Tennessee Res Corp Medicamento para tratamento de neoplasia intra-epitelial prostatica

Also Published As

Publication number Publication date
AU761435B2 (en) 2003-06-05
CZ300960B6 (cs) 2009-09-23
NO20005625D0 (no) 2000-11-07
CZ20004118A3 (cs) 2002-07-17
EA200000100A1 (ru) 2000-08-28
ATE283043T1 (de) 2004-12-15
JP2002513755A (ja) 2002-05-14
IL193231A0 (en) 2009-02-11
PT1003496E (pt) 2005-04-29
JP4482229B2 (ja) 2010-06-16
CA2323809C (en) 2007-09-18
HUP0102068A3 (en) 2002-11-28
JP2008163048A (ja) 2008-07-17
PL344000A1 (en) 2001-09-10
BG105022A (bg) 2001-07-31
TR200003269T2 (tr) 2001-02-21
EP1475087A2 (en) 2004-11-10
DE69922131D1 (de) 2004-12-30
IL138437A (en) 2008-12-29
NO20005625L (no) 2001-01-05
PL207462B1 (pl) 2010-12-31
DE1003496T1 (de) 2000-11-02
EP1475087A3 (en) 2007-07-11
DE69922131T2 (de) 2005-11-24
EP1003496B1 (en) 2004-11-24
EA003466B1 (ru) 2003-06-26
EP2277514A1 (en) 2011-01-26
HUP0102068A2 (hu) 2002-05-29
CA2323809A1 (en) 1999-11-11
IS8354A (is) 2006-03-15
AU4072699A (en) 1999-11-23
BG65597B1 (bg) 2009-02-27
IL138437A0 (en) 2001-10-31
ES2145730T1 (es) 2000-07-16
WO1999056739A1 (en) 1999-11-11
IS2213B (is) 2007-03-15
DK1003496T3 (da) 2005-04-04
NZ527522A (en) 2005-04-29
EP1003496A1 (en) 2000-05-31
SI1003496T1 (en) 2005-10-31
UA74532C2 (en) 2006-01-16
HRP20000729A2 (en) 2001-06-30
US6265448B1 (en) 2001-07-24
ES2145730T3 (es) 2005-06-16
YU68600A (sh) 2003-12-31
SK16642000A3 (sk) 2002-08-06

Similar Documents

Publication Publication Date Title
IS8354A (is) Aðferð til að koma í veg fyrir krabbamein í blöðruhálskirtli með lyfjagjöf
CA2289202A1 (en) Solid pharmaceutical formulations containing a physical mixture of sulfoalkyl ether cyclodextrin and a therapeutic agent
AU2002236765A1 (en) Pharmaceutical combination for the treatment of cancer containing a 4-quinazolineamine and another anti-neoplastic agent
ATE232087T1 (de) Feste lösungen und dispersionen von eines schlecht wasserlöslichen wirkstoffes
BR0200155A (pt) Tratamento combinado para depressão
BR0114576A (pt) Composto, composição farmacêutica, uso de um composto, método de tratar um estado doentio e processo para preparar um composto
NO20024586D0 (no) Metode og preparater for å forhindre hormoninduserte bivirkninger
BR9806118A (pt) Processos para tratamento de pigmentação de pele
IL140848A (en) Pharmaceutical compositions containing phenylacetylglutamine, phenylacetylisoglutamine and/or phenylacetate
MXPA01012882A (es) Composiciones y metodos que comprenden gluconato de morfina.
AR021370A1 (es) Composiciones farmaceuticas inyectables estabilizadas que contienen agentes anti-neoplasicos taxoides
DE60019334D1 (de) Antivirale arznei
WO2001052897A3 (en) Therapeutic anti-inflammatory and analgesic composition containing selective cox-2 inhibitors
EP0240131A3 (en) Tamoxifen for topical use
NO20010052L (no) NAALADase inhibitorer anvendbare som farmasöytiske forbindelser og preparater
WO2001041751A8 (en) Phytoestrogens for treating als
HU911928D0 (en) Process for the production of chelates and its complexes containing orto ligating functional group, and the medical preparations containing thereof
ES2174297T3 (es) Nuevos derivados de piranosidos.
MXPA03006359A (es) Metodo para tratamiento del cancer.
ATE317685T1 (de) Mindestens ein dibenzoylmethanderivat und 1,1,3,- tri-(2-methyl-4-hydroxy-5-tert-butylphenyl)-but n enthaltende filterzusammensetzung
NZ510445A (en) A method for intrahepatic administration of methoxymorpholino doxorubicin (MMDX) to achieve a high concentration at a hepatic tumour site
WO2002076400A3 (en) Inosine compounds and their use for treating or preventing an inflamation or a reperfusion disease
AU4650001A (en) Agent for coloring fibers and method for temporarily coloring fibers
WO2002094183A3 (en) A method for tumor treatment with fumagillol derivatives
TR200101157T2 (tr) Bitkiden elde edilen antiparazit ve antimantar bileşikleri ve bileşikleri çıkartma yöntemleri.